Lapatinib

CHF 60.00
In stock
SYN-1052-M0011 mgCHF 60.00
SYN-1052-M0055 mgCHF 72.00
SYN-1052-M01010 mgCHF 84.00
SYN-1052-M05050 mgCHF 227.00
SYN-1052-M100100 mgCHF 323.00
 
More Information
Product Details
Synonyms GW-572016
Product Type Chemical
Properties
Formula C29H26ClFN4O4S
MW 581.1
CAS 231277-92-2
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: EGFR | Kinase Group: RTK | Substrate: Tyrosine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key BCFGMOOMADDAQU-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Lapatinib is an ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor, with IC(50) values of 10.8 and 9.2nM respectively. It is an orally active drug for treatment of breast cancer and other solid tumors.
Product References
  1. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways: W. Xia, et al.; Oncogene 21, 6255 (2002)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.